The American Skin Association (ASA) announced 13 recipients for its 2026 research grants, expanding its focus to include hidradenitis suppurativa, systemic mastocytosis, and anti-obesity medication applications. Sun Pharma contributed $300,000 to fund three Investigative Scientist Awards, while other grants were supported by corporate partners including Sanofi, Blueprint Medicines, and Johnson & Johnson.
Johnson & Johnson is named as sponsor of the ASA Johnson & Johnson Research Grant in Psoriasis. A named academic research grant is routine philanthropy with no financial figures that would change earnings or outlook; it may offer modest reputational benefit in dermatology.